- cafead Nov 17, 2020 at 11:52: AM
via Pandemic travel restrictions have shut down many of pharma's paid healthcare provider speaker programs—and the U.S. Department of Health and Human Services (HHS) thinks it should stay that way.
In a Special Fraud Alert issued (PDF) Monday by its inspector general’s office, HHS urged pharma companies and device makers to reconsider restarting in-person paid healthcare professional speaker programs when COVID-19 restrictions lift.
article source
In a Special Fraud Alert issued (PDF) Monday by its inspector general’s office, HHS urged pharma companies and device makers to reconsider restarting in-person paid healthcare professional speaker programs when COVID-19 restrictions lift.
article source